Testosterone therapy and cardiovascular risk

James P. Walsh, Anne C. Kitchens

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Endogenous testosterone levels are inversely associated with cardiovascular risk in older men and men with cardiovascular disease. Current data on cardiovascular outcomes of testosterone therapy include only observational studies and adverse event monitoring in short-term trials that were not designed to measure cardiovascular outcomes. These studies have yielded conflicting results, and some have raised concerns that testosterone therapy may increase cardiovascular risk. A well-designed, adequately powered, prospective trial will ultimately be required to clarify whether testosterone therapy impacts cardiovascular outcomes. This review describes the findings and limitations of recent studies of cardiovascular risk in older men on testosterone therapy and discusses some of the mechanisms through which testosterone may modify cardiovascular risk.

Original languageEnglish
Pages (from-to)250-257
Number of pages8
JournalTrends in Cardiovascular Medicine
Volume25
Issue number3
DOIs
StatePublished - Apr 1 2015

Fingerprint

Testosterone
Therapeutics
Observational Studies
Cardiovascular Diseases
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Testosterone therapy and cardiovascular risk. / Walsh, James P.; Kitchens, Anne C.

In: Trends in Cardiovascular Medicine, Vol. 25, No. 3, 01.04.2015, p. 250-257.

Research output: Contribution to journalArticle

Walsh, James P. ; Kitchens, Anne C. / Testosterone therapy and cardiovascular risk. In: Trends in Cardiovascular Medicine. 2015 ; Vol. 25, No. 3. pp. 250-257.
@article{b20c1f2b75994292a6797477b4da0122,
title = "Testosterone therapy and cardiovascular risk",
abstract = "Endogenous testosterone levels are inversely associated with cardiovascular risk in older men and men with cardiovascular disease. Current data on cardiovascular outcomes of testosterone therapy include only observational studies and adverse event monitoring in short-term trials that were not designed to measure cardiovascular outcomes. These studies have yielded conflicting results, and some have raised concerns that testosterone therapy may increase cardiovascular risk. A well-designed, adequately powered, prospective trial will ultimately be required to clarify whether testosterone therapy impacts cardiovascular outcomes. This review describes the findings and limitations of recent studies of cardiovascular risk in older men on testosterone therapy and discusses some of the mechanisms through which testosterone may modify cardiovascular risk.",
author = "Walsh, {James P.} and Kitchens, {Anne C.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.tcm.2014.10.014",
language = "English",
volume = "25",
pages = "250--257",
journal = "Trends in Cardiovascular Medicine",
issn = "1050-1738",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Testosterone therapy and cardiovascular risk

AU - Walsh, James P.

AU - Kitchens, Anne C.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Endogenous testosterone levels are inversely associated with cardiovascular risk in older men and men with cardiovascular disease. Current data on cardiovascular outcomes of testosterone therapy include only observational studies and adverse event monitoring in short-term trials that were not designed to measure cardiovascular outcomes. These studies have yielded conflicting results, and some have raised concerns that testosterone therapy may increase cardiovascular risk. A well-designed, adequately powered, prospective trial will ultimately be required to clarify whether testosterone therapy impacts cardiovascular outcomes. This review describes the findings and limitations of recent studies of cardiovascular risk in older men on testosterone therapy and discusses some of the mechanisms through which testosterone may modify cardiovascular risk.

AB - Endogenous testosterone levels are inversely associated with cardiovascular risk in older men and men with cardiovascular disease. Current data on cardiovascular outcomes of testosterone therapy include only observational studies and adverse event monitoring in short-term trials that were not designed to measure cardiovascular outcomes. These studies have yielded conflicting results, and some have raised concerns that testosterone therapy may increase cardiovascular risk. A well-designed, adequately powered, prospective trial will ultimately be required to clarify whether testosterone therapy impacts cardiovascular outcomes. This review describes the findings and limitations of recent studies of cardiovascular risk in older men on testosterone therapy and discusses some of the mechanisms through which testosterone may modify cardiovascular risk.

UR - http://www.scopus.com/inward/record.url?scp=84925218589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925218589&partnerID=8YFLogxK

U2 - 10.1016/j.tcm.2014.10.014

DO - 10.1016/j.tcm.2014.10.014

M3 - Article

C2 - 25467243

AN - SCOPUS:84925218589

VL - 25

SP - 250

EP - 257

JO - Trends in Cardiovascular Medicine

JF - Trends in Cardiovascular Medicine

SN - 1050-1738

IS - 3

ER -